Stockreport

Innovus Pharmaceuticals Reports Preliminary Q1 2019 Sales Revenue of Approximately $5.4 million

InnovAge Holding Corp.  (INNV) 
NASDAQ:AMEX Investor Relations: innovuspharma.com
PDF Preliminary Quarterly Revenue Increase of 12.8% Comparable to 2018 Fourth Quarter and Increase of 18.0% Comparable to 2018 First Quarter SA [Read more]